Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.63 |
| ▸ | NPC1 | O15118 | 6/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309593 | 0.89 | GRM4 (0.52) | RAB9ANPC1POLBSMN1; SMN2TP53 | |
| SCHEMBL23309477 | 0.87 | ATF1 (0.51) | RAB9ANPC1POLBSMN1; SMN2TP53 | |
| SCHEMBL23309612 | 0.87 | GRM4 (0.47) | RAB9ANPC1POLBSMN1; SMN2TP53 | |
| SCHEMBL23309511 | 0.87 | KMT2A (0.52) | RAB9ANPC1POLBSMN1; SMN2RXFP1 | |
| SCHEMBL23309585 | 0.86 | KDM4E (0.52) | RAB9ANPC1POLBSMN1; SMN2RXFP1 | |
| SCHEMBL23309617 | 0.86 | NPC1 (0.54) | RAB9ANPC1POLBSMN1; SMN2TP53 | |
| SCHEMBL23309615 | 0.85 | P2RX1 (0.58) | RAB9ANPC1ALDH1A1GAAGRM4 | |
| SCHEMBL23309536 | 0.83 | MEN1 (0.55) | RAB9ANPC1SMN1; SMN2TP53RXFP1 | |
| SCHEMBL23309575 | 0.82 | RXFP1 (0.69) | RAB9ANPC1SMN1; SMN2TP53RXFP1 | |
| SCHEMBL23309490 | 0.81 | GAA (0.51) | RAB9ANPC1POLBSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | RAB9A 286/4885NPC1 412/4885POLB 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.